BioAdaptives Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BioAdaptives Inc. (BDPT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 540.21 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-19
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 266.77M shares, a 126.91% increase year-over-year.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 117.56M shares, a 862.40% increase year-over-year.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 12.22M shares, a 99.01% decline year-over-year.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 1.24B shares.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 190.22M shares, a 71.17% increase from fiscal 2024.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 111.13M shares, a 3608.75% increase from fiscal 2023.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.00M shares, a 99.74% decline from fiscal 2022.
- BioAdaptives Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.14B shares, a 1643.25% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 540.21M shares 10-Q · filed 2026-08-19 | |||||||
| 2026-03-31 | 266.77M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 190.22M shares 10-K · filed 2026-04-14 | |||||||
| 2025-09-30 | 143.72M shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 117.56M shares 10-Q · filed 2026-08-19 | 127.50M shares 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | 117.56M shares 10-Q · filed 2026-05-15 | 117.56M shares 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | 111.13M shares 10-K · filed 2026-04-14 | |||||||
| 2024-09-30 | 112.52M shares 10-Q · filed 2025-11-14 | 2.40B shares 10-Q · filed 2024-11-19 | ||||||
| 2024-06-30 | 112.52M shares 10-Q · filed 2025-08-14 | 1.91B shares 10-Q · filed 2024-08-19 | ||||||
| 2024-03-31 | 12.22M shares 10-Q · filed 2025-05-13 | 1.86B shares 10-Q · filed 2024-05-17 | ||||||
| 2023-12-31 | 3.00M shares 10-K · filed 2025-04-15 | 2.05B shares 10-K · filed 2024-04-10 | ||||||
| 2023-09-30 | 898.93M shares 10-Q · filed 2024-11-19 | |||||||
| 2023-06-30 | 870.18M shares 10-Q · filed 2024-08-19 | |||||||
| 2023-03-31 | 1.24B shares 10-Q · filed 2024-05-17 | |||||||
| 2022-12-31 | 1.14B shares 10-K · filed 2024-04-10 | |||||||
| 2021-12-31 | 65.51M shares 10-K · filed 2023-03-31 | |||||||
| 2020-12-31 | 36.25M shares 10-K · filed 2022-03-31 | |||||||
| 2019-12-31 | 4.73M shares 10-K · filed 2021-03-30 |